Hikma and CanariaBio sign exclusive licensing agreement to bring Oregovomab to the Middle East and North Africa
London, United Kingdom – Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces an…More
London, United Kingdom – Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces an…More
CHAILLÉ-SOUS-LES-ORMEAUX, France — Hoffmann Green Cement Technologies (ISIN: FR0013451044, Mnemo: ALHGR) (Paris:ALHGR) (“Hoffmann Green Cement”…More
London, United Kingdom — Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces a new exclusive…More